Ischaemic and haemorrhagic stroke associated with non-vitamin K antagonist oral anticoagulants and warfarin use in patients with atrial fibrillation: a nationwide cohort study - Concepedia

Concepedia

Publication | Open Access

Ischaemic and haemorrhagic stroke associated with non-vitamin K antagonist oral anticoagulants and warfarin use in patients with atrial fibrillation: a nationwide cohort study

DOI Full Paper Access

90

Citations

16

References

2016

Year

Emil Loldrup Fosbøl, Gregory Y.H. Lip, Morten Lamberts, Anders Nissen Bonde, Christian Torp‐Pedersen, Brice Ozenne, Thomas Alexander Gerds, Gunnar Gislason, Jonas Bjerring Olesen

European Heart Journal

Abstract

Among anticoagulant-naïve AF patients, treatment with NOACs was not associated with significantly lower risk of stroke/TE compared with VKA, but intracranial bleeding risk was significantly lower with dabigatran and apixaban.

References

	Year	Citations
Dabigatran versus Warfarin in Patients with Atrial Fibrillation Stuart J. Connolly, Michael D. Ezekowitz, Salim Yusuf, New England Journal of Medicine	2009	11.1K
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation Manesh R. Patel, Kenneth W. Mahaffey, Jyotsna Garg, New England Journal of Medicine	2011	9.3K
Apixaban versus Warfarin in Patients with Atrial Fibrillation Christopher B. Granger, John H. Alexander, John J.V. McMurray, New England Journal of Medicine	2011	8.8K
Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Philip A. Wolf, Robert D. Abbott, W B Kannel Stroke HypertensionHeart FailureCerebrovascular DiseasePreventive CardiologyAcute Myocardial Infarction	1991	7.4K
The Danish Civil Registration System Carsten Bøcker Pedersen Scandinavian Journal of Public Health	2011	4.5K
The Danish National Patient Register Elsebeth Lynge, Jakob Lynge Sandegaard, Matejka Rebolj Scandinavian Journal of Public Health	2011	3.9K
The Danish National Prescription Registry Helle Wallach‐Kildemoes, Henrik Toft Sørensen, Jesper Hallas Scandinavian Journal of Public Health	2011	2.4K
Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial Lars Wallentin, Salim Yusuf, Michael D. Ezekowitz, The Lancet ThrombosisVenous ThrombosisCardiovascular DiseaseStrokeRe-ly Trial	2010	1K
Marginal Structural Models as a Tool for Standardization Tosiya Sato, Yutaka Matsuyama Epidemiology Treatment EffectEducationStructural ProblemCausal InferenceNonparametric Standardization	2003	453
Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a ‘real world’ nationwide cohort study Gregory Y.H. Lip, Jesper Lindhardsen, Deirdre A. Lane, Thrombosis and Haemostasis	2011	427

Page 1